Investing Ideas
/
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Apr 20, 2024

Companies with a Value score of at least 3, ordered by Value score

461 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	BIOV.F Swedish Orphan Biovitrum	kr22.87	-8.5%	-13.4%	kr88.7b	kr27.52	PE36.8x	E21.7%	n/a
	LMLL.F Pharmadrug	CA$0.021	-11.5%	-57.2%	CA$3.7m	n/a	PE2.5x	n/a	n/a
	CLVL.F Clinuvel Pharmaceuticals	AU$9.51	-1.5%	-30.2%	AU$720.5m	AU$16.54	PE23.9x	E12.3%	0.3%
	HKMP.Y Hikma Pharmaceuticals	UK£46.50	-1.3%	1.1%	UK£4.0b	UK£59.47	PE26x	E18.1%	3.2%
	SNDL SNDL	US$1.87	-6.5%	29.9%	US$492.0m	US$3.61	PB0.6x	E135.8%	n/a

Page 20 of 20